Using machine learning to improve flu vaccines
Official title: Machine Learning to Modulate Influenza Immunity
Funded at Vanderbilt University · NIH-11017530 · Data updated 2026-11-12
This study is working on using smart computer technology to create better flu vaccines that can help protect you longer and more effectively against the virus.
Quick facts
| Grant type | U01 cooperative agreement |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Vanderbilt University NIH-funded |
| Lab location | 1 site (Nashville, UNITED STATES) |
| Project start | May 19, 2025 |
| Project end | April 30, 2030 |
| Funding year | 2025 |
| Award (this year) | $1,195,056 |
| NIH project number | 1U01AI187059-01 |
| Project ID | NIH-11017530 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals who are at higher risk for influenza, such as the elderly, young children, and those with compromised immune systems.
✕Less likely to help
Patients who are not at risk for influenza or those who have already received a flu vaccine may not receive significant benefits from this research.
What this research studies
This research focuses on developing advanced computational tools that utilize machine learning to create more effective vaccines against influenza. By integrating artificial intelligence with traditional biology, the project aims to design vaccines that provide broader and longer-lasting immunity. The approach includes innovative strategies such as targeting specific parts of the virus and refining vaccine candidates based on experimental feedback. Patients may benefit from vaccines that are more effective in preventing influenza infections.
Why it matters
Potential benefit: If successful, this research could lead to the development of a more effective flu vaccine that provides broader protection against various strains of the virus.
How similar studies have gone: Other research has shown promise in using machine learning for vaccine development, indicating that this approach could lead to significant advancements in immunization strategies.
Where this research is happening
-
Vanderbilt University
Nashville, United States Active
Researchers
- Principal investigator: Meiler, Jens — Vanderbilt University
- Study coordinator: Meiler, Jens
Related research
Other NIH-funded projects on the same topics.
-
Creating vaccines for influenza and other infectious diseases
This study is all about creating new vaccines to help protect people from the flu and other infections, so patients can look forward to better options for staying healthy.
-
Creating vaccines for human trials against influenza and other infectious diseases
This study is working on creating new vaccines to help protect people from flu and other infectious diseases, including those that could be used in harmful situations, so that everyone can have safer and more effective options to stay healthy.
-
Understanding flu and COVID-19 vaccine responses in people and in the lab
Researchers at Stanford explore how flu and COVID-19 vaccines work in people and in lab tests to improve protection for adults.
-
Surveillance and preparedness for flu and other respiratory pathogens in Kenya
A US-based research grant aims to improve how Kenya detects and prepares for influenza and other respiratory diseases to protect people there and global health.
-
Enhanced Seasonal Influenza Vaccine Targeting Shared and Variable Viral Antigens
A new DNA-based influenza vaccine approach aims to provide both precise protection against circulating strains and broader defense against unexpected strains.
-
How the immune system responds to flu shots and flu infection
This project looks at how adults' immune systems react after flu shots or when they catch the flu to find why some people get better protection than others.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.